These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ocular penetration of N-formimidoyl thienamycin (MK-787) and potentiation by dipeptidase inhibitor (MK-791). Finlay KR; Carlson CL; Chow AW Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1147-9. PubMed ID: 6575970 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of N-formimidoyl thienamycin and influence of a renal dipeptidase inhibitor in experimental meningitis. Washburn DE; Perfect JR; Durack DT J Antimicrob Chemother; 1983 Jul; 12(1):39-45. PubMed ID: 6578210 [TBL] [Abstract][Full Text] [Related]
5. Single-dose pharmacokinetics of imipenem-cilastatin in neonates. Gruber WC; Rench MA; Garcia-Prats JA; Edwards MS; Baker CJ Antimicrob Agents Chemother; 1985 Apr; 27(4):511-4. PubMed ID: 3859243 [TBL] [Abstract][Full Text] [Related]
6. Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin. Birnbaum J; Kahan FM; Kropp H; MacDonald JS Am J Med; 1985 Jun; 78(6A):3-21. PubMed ID: 3859213 [TBL] [Abstract][Full Text] [Related]
7. A randomized study comparing clinical efficacy and safety of thienamycin formamidine (MK0787)/renal dipeptidase inhibitor (MK0791) and cefazolin. Ribner BS; Raeder R; Hollstein M; Freimer EH J Antimicrob Chemother; 1983 Oct; 12(4):387-91. PubMed ID: 6358177 [TBL] [Abstract][Full Text] [Related]
10. Penetration of imipenem and cilastatin into cerebrospinal fluid of patients with bacterial meningitis. Modai J; Vittecoq D; Decazes JM; Meulemans A J Antimicrob Chemother; 1985 Dec; 16(6):751-5. PubMed ID: 3867660 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans. Norrby SR; Alestig K; Ferber F; Huber JL; Jones KH; Kahan FM; Meisinger MA; Rogers JD Antimicrob Agents Chemother; 1983 Feb; 23(2):293-9. PubMed ID: 6573156 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections. Jacobs RF; Kearns GL; Brown AL; Longee DC Antimicrob Agents Chemother; 1986 Apr; 29(4):670-4. PubMed ID: 3458427 [TBL] [Abstract][Full Text] [Related]
13. [Fundamental and clinical studies of imipenem/cilastatin sodium in the field of obstetrics and gynecology. Study group of imipenem/cilastatin sodium in the field of obstetric and gynecological infections]. Matsuda S; Suzuki M; Hasegawa Y; Ninomiya K; Shimizu T; Maeda Y; Ichinoe K; Makinoda S; Sato H; Sato H Jpn J Antibiot; 1986 Jun; 39(6):1626-55. PubMed ID: 3531568 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis. Reed MD; Stern RC; O'Brien CA; Yamashita TS; Myers CM; Blumer JL Antimicrob Agents Chemother; 1985 Apr; 27(4):583-8. PubMed ID: 3859245 [TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of imipenem/cilastatin sodium in gynecological infection]. Iwaki M; Sato H; Makinoda S; Demise M; Tabata M; Yamaguchi T; Takaoka H; Shinkai N; Okubo H; Sato H Jpn J Antibiot; 1986 Jun; 39(6):1509-13. PubMed ID: 3463791 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bacteriological efficacy of N-formimidoyl thienamycin in experimental Escherichia coli meningitis. Patamasucon P; McCracken GH Antimicrob Agents Chemother; 1982 Mar; 21(3):390-2. PubMed ID: 7049073 [TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure. Verpooten GA; Verbist L; Buntinx AP; Entwistle LA; Jones KH; De Broe ME Br J Clin Pharmacol; 1984 Aug; 18(2):183-93. PubMed ID: 6593092 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of imipenem-cilastatin in neonates. Freij BJ; McCracken GH; Olsen KD; Threlkeld N Antimicrob Agents Chemother; 1985 Apr; 27(4):431-5. PubMed ID: 3859242 [TBL] [Abstract][Full Text] [Related]
19. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial. Calandra GB; Hesney M; Brown KR Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of granulocyte functions in vitro by imipenem and the renal enzyme inhibitor MK 0791. Gnarpe H; Belsheim J; Blomqvist C; Lundbäck A Antimicrob Agents Chemother; 1984 Feb; 25(2):179-81. PubMed ID: 6585179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]